Circulating Butyrate Attenuates Cetuximab Efficacy in Colorectal Cancer Through EGFR and AMPK-Wip1 Signaling.

In the absence of CTX, NaBu slightly promoted tumor growth and metastasis, although these differences did not reach statistical significance.

also in 111,027 other papers